The U.S. Food and Drug Administration has announced an official review of all-metal hip implants, in response to growing concerns about their reported early failure rates.
According to a Reuters report, the FDA has scheduled an advisory panel for June 27 and 28, which will gather input from scientists, researchers, patients and medical practitioners. Panel members will examine the question of whether medical devices should be subject to new testing standards and review requirements before going on the market in the ...
continue reading...